Literature DB >> 7549466

Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.

M Spaargaren1, J R Bischoff, F McCormick.   

Abstract

Members of the ras family of GTPases are involved in a wide variety of cellular processes including cell proliferation, differentiation, apoptosis, and transformation. The ras oncogene is one of the most frequently mutated genes in human cancer. In addition, other oncogene and tumor suppressor gene products are components of the signal transduction pathways in which Ras or other Ras-like GTPases play key regulatory functions. Current progress in the elucidation of these signal transduction pathways will be reviewed and the potential use of these insights for the development of novel therapeutic agents for the treatment of cancer will be discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549466      PMCID: PMC6134362     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  118 in total

1.  Association of pRas and pRaf-1 in a complex correlates with activation of a signal transduction pathway.

Authors:  R E Finney; S M Robbins; J M Bishop
Journal:  Curr Biol       Date:  1993-12-01       Impact factor: 10.834

2.  Chimeric proteins define variable and essential regions of Ha-ras-encoded protein.

Authors:  D G Lowe; M Ricketts; A D Levinson; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Comparison of kinetic properties between two mammalian ras p21 GDP/GTP exchange proteins, ras guanine nucleotide-releasing factor and smg GDP dissociation stimulation.

Authors:  S Orita; K Kaibuchi; S Kuroda; K Shimizu; H Nakanishi; Y Takai
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

4.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

5.  Association of a Ras-related protein with cytochrome b of human neutrophils.

Authors:  M T Quinn; C A Parkos; L Walker; S H Orkin; M C Dinauer; A J Jesaitis
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

6.  R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.

Authors:  I Rey; P Taylor-Harris; H van Erp; A Hall
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

7.  Inhibition by cAMP of Ras-dependent activation of Raf.

Authors:  S J Cook; F McCormick
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

8.  Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase.

Authors:  M Spaargaren; L H Defize; J Boonstra; S W de Laat
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

9.  Enhancement of the actions of smg p21 GDP/GTP exchange protein by the protein kinase A-catalyzed phosphorylation of smg p21.

Authors:  Y Hata; K Kaibuchi; S Kawamura; M Hiroyoshi; H Shirataki; Y Takai
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

10.  Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein.

Authors:  S J Leevers; C J Marshall
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  11 in total

Review 1.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 2.  Roles for KRAS in pancreatic tumor development and progression.

Authors:  Marina Pasca di Magliano; Craig D Logsdon
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 3.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

4.  Cancerous epithelial cell lines shed extracellular vesicles with a bimodal size distribution that is sensitive to glutamine inhibition.

Authors:  Steven Michael Santana; Marc A Antonyak; Richard A Cerione; Brian J Kirby
Journal:  Phys Biol       Date:  2014-11-26       Impact factor: 2.583

5.  Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies.

Authors:  Y Liao; Z Y Tang; K D Liu; S L Ye; Z Huang
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Oncogenic K-Ras requires activation for enhanced activity.

Authors:  H Huang; J Daniluk; Y Liu; J Chu; Z Li; B Ji; C D Logsdon
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

7.  Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.

Authors:  Ntube N O Ngalame; Anthony L Luz; Ngome Makia; Erik J Tokar
Journal:  Toxicol Sci       Date:  2018-09-01       Impact factor: 4.849

8.  Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis.

Authors:  Jie-Ying Chen; Ya-Nan Cheng; Lei Han; Feng Wei; Wen-Wen Yu; Xin-Wei Zhang; Shui Cao; Jin-Pu Yu
Journal:  Cancer Biol Med       Date:  2015-06       Impact factor: 4.248

9.  The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment.

Authors:  Hongzhi Sun; Bo Zhang; Haijun Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 10.  The Significance of Mitochondrial Dysfunction in Cancer.

Authors:  Yongde Luo; Jianjia Ma; Weiqin Lu
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.